Speciality: Cardiology
Description:
.A warm welcome to all the medical professionals in this interesting session on Metoprolol Tartrate in Cardiovascular disease management.
Metoprolol tartrate plays a pivotal role in managing cardiovascular disease (CVD), particularly in conditions like hypertension, angina, and heart failure. As a beta-blocker, it works by blocking the effects of adrenaline, thereby slowing down the heart rate and reducing blood pressure. In hypertensive patients, metoprolol tartrate helps to relax blood vessels, easing the workload on the heart and improving blood flow.
In the management of angina, metoprolol tartrate reduces the frequency and severity of chest pain episodes by decreasing the heart's oxygen demand. By slowing the heart rate and reducing contractility, it improves myocardial oxygen supply-demand balance. This alleviates symptoms and enhances the patient's quality of life.
Metoprolol tartrate is also beneficial in heart failure management, particularly in patients with reduced ejection fraction. It helps to improve symptoms, reduce hospitalizations, and prolong survival by blocking harmful effects of catecholamines on the heart, leading to decreased myocardial workload and improved cardiac function.
Therefore, get an overall knowledge of metoprolol tartrate in cardiovascular disease management.Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment
2.
A small rise in cancer was observed following the 1986 Chernobyl accident.
3.
First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.
4.
New research uncovers link between cancer pathway and blood-retina barrier function
5.
Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases
1.
Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians
2.
Survivorship Planning Beyond Active Cancer Care
3.
Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options
4.
Integrated Models in Hematology for Specialists
5.
Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation